Jeff Yass’s MAIA Biotechnology MAIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.7K Buy
+35,223
New +$46.8K ﹤0.01% 12821
2026
Q1
Sell
-14,288
Closed -$21.9K 13710
2025
Q4
$21.9K Buy
14,288
+2,673
+23% +$3.49K ﹤0.01% 11937
2025
Q3
$17.9K Buy
+11,615
New +$19K ﹤0.01% 12064
2025
Q2
Sell
-55,100
Closed -$84.3K 13284
2025
Q1
$84.3K Buy
55,100
+43,451
+373% +$80.4K ﹤0.01% 11644
2024
Q4
$23.1K Buy
+11,649
New +$27.9K ﹤0.01% 11895

Other funds holding MAIA

Jeff Yass's MAIA Position: Q2 2026 in Review

Jeff Yass opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 35,223 shares worth $50.7K. The stake represents ﹤0.01% of the portfolio and ranks #12821 among its holdings. This is a return to the name: Jeff Yass previously reported a position in MAIA as recently as Q4 2025.

Jeff Yass first reported a position in MAIA in Q4 2024 and has held it in 5 quarters since. The position peaked at $84.3K in Q1 2025. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Jeff Yass held 35,223 shares of MAIA Biotechnology worth $50.7K as of Q2 2026.
  • MAIA Biotechnology was a new Jeff Yass position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12821 holding.
  • Jeff Yass first reported a position in MAIA Biotechnology in Q4 2024 and has held it in 5 quarters since.
  • Jeff Yass's MAIA Biotechnology position peaked at $84.3K in Q1 2025.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.